RecallReported November 4, 2026
Class II recall by Eagle Pharma Outsourcing LLC
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTS…
FDA's enforcement report of November 4, 2026 lists a Class II recall by Eagle Pharma Outsourcing LLC of Hoover, AL. Product: PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTS…. Status: Ongoing.
On the record
- Recalling firm
- Eagle Pharma Outsourcing LLC
- Location
- Hoover, AL
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0105-2027
- Product type
- Drugs
- Recall initiated
- 2026-10-08
- Reported by FDA
- 2026-11-04
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Eagle Pharma Outsourcing LLC
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Eagle Pharma Outsourcing LLC.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.